Prof. Robert Vince honored for his innovative work
Prof. Robert Vince received the Impact Award at the inaugural presentation of the Innovation Awards (2014). At the ceremony, Made in Minnesota: Celebrating University Innovators, President Kaler awarded the trophy to Prof Vince.
Research on Alzheimer's Disease by Prof Vince and Prof More Featured on C&EN News
Eye Test Might One Day Diagnose Alzheimer’s Before Symptoms Appear
Prof Swati More and Prof Robert Vince have developed a noninvasive imaging technique that tracks accumulation of the Alzheimer’s peptide, amyloid-β, in the eye. The pair have peered into the retinas of mice with their patented, microscope-based method, they hope to one day use it to identify Alzheimer’s disease in human patients years before symptoms manifest.
OakleyOriginals/CC 2.0/ flic.kr/p/5pjoeg
Prof Chen's Research on Parkinson’s Disease featured by the University
Drug Design for Parkinson’s Disease Starts Here
Recently, University of Minnesota Center for Drug Design member, organic chemist and assistant professor Prof Liqiang Chen, published a paper in the Journal of Medicinal Chemistry outlining the discovery of a potent and selective protein-inhibitor. Blocking the protein, Sirtuin 2 (SIRT2), also has the potential to block a primary contributor to Parkinson’s disease from causing harm.
Underground Research Drives Drug Research
Prof Salomon's Research Highlighted in MNDaily
University of Minnesota researchers have been studying microorganisms living in the Soudan Underground Mine, 224 miles north of the Twin Cities. For about five years, they’ve catalogued the organisms capable of living there despite the mine’s harsh conditions, and they hope that their discoveries will lead them to new treatments for disease and new technology.
Message from the Director
Robert Vince, PhD
The Center for Drug Design (CDD) was created to combine research and scholarship leading to the development of novel drugs for therapeutic applications, such as HIV, cancer, neurological diseases, dermatological agents, infectious diseases, novel processes, and medical devices. The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value for our academic and research community.
Susan Mooberry, PhD
Professor of Pharmacology and Co-leader of Experimental & Developmental Therapeutics
Cancer Therapy & Research Center
The University of Texas Health Science Center at San Antonio
Date: May 20, 2015
Time: 10:30 - 11:30 AM
Spotlight on Research
A faster acting and safer than existing options, an antidote for cyanide poisoning that works prophylactically to prevent or limit toxicity associated from exposure to cyanide has been developed.